Navigation Links
Antibacterial Drugs: World Market Prospects 2012-2022
Date:12/27/2011

bactam, AstraZeneca/Forest Laboratories)

6.8 CXA-201 (Cubist)

6.9 NKTR-061 (Amikacin Inhalation, Bayer/Nektar Therapeutics)

6.10 Ramoplanin (Nanotherapeutics)

6.11 Radezolid (Rib-X Pharmaceuticals)

7. Antibacterial Drugs: Industry Trends 2012-2022

7.1 Strengths and Weaknesses in the Antibacterial Drugs Market 2011

7.2 Opportunities and Threats in the Antibacterial Drugs Market 2012-2022

7.3 Late-Stage Pipeline Therapies

7.3.1 Governmental Incentives

7.4 New Strategies

7.4.1. Monoclonal Antibodies

7.4.2 Inhaled Antibiotics for Hospital-Acquired Pneumonia

7.5 Bacterial Resistance: An Opportunity and a Threat

7.5.1 Emerging Resistance

7.5.2 Restricting Drug Use

7.6 The Challenge of Non-Inferiority Trials

7.7 Improved Regulatory Guidance

7.8 Lifecycle Management

7.9 Hospital-Acquired Infections

7.9.1 Treating Hospital-Acquired Infections

7.9.2 Preventing Hospital-Acquired Infections

7.9.3 Hospital Hygiene

7.9.4 Tracking Infections

7.9.5 Advances in Hospital Equipment

7.9.5.1 Copper Kills Bacteria

8. Research Interviews8.1 Professor Malcolm Page, Head of Biology, Basilea Pharmaceutica

8.1 Professor Malcolm Page, Head of Biology, Basilea Pharmaceutica

8.1.1 Basilea Pharmaceutica

8.1.2 Antibacterial Research This Decade

8.1.3 Challenges in Developing Treatments for Gram-Negative Bacteria

8.1.4 Overcoming Drug Resistance

8.1.5 New Targets for Antibacterial Drug Development

8.2 Dr Michael Rudolf, CSO, Kenta Biotech

8.2.1 Kenta Biotech

8.2.2 Monoclonal Antibodies for Bacterial Infections

8.2.3 Challenges in Developing Treatments for Gram-Negative Bacteria

8.2.4 Unmet Needs in the Antibacterial Drugs Market

9. Conclusions from Our Study

9.1 Antibacterial Drugs Market 2012-2022

9.1.1
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. PTC Therapeutics Antibacterial Program Receives $5 Million Award from the Wellcome Trust
2. Reportlinker Adds The Antibacterials Market Outlook to 2016
3. Reportlinker Adds Forecast Insight: Antibacterials
4. FDA Clears Single-Use Antibacterial Surgical Respirator
5. Cempra Expands Clinical Management Team to Advance Leading Antibacterial Clinical Programs Solithromycin and TAKSTA™
6. TYRX Presents Early Clinical Results from AIGISRX(TM) Antibacterial Envelope Retrospective Registry
7. Trius Doses First Patient in Antibacterial Phase 2 Trial
8. Trius Initiates U.S. Phase I Trial for its Oxazolidinone Antibacterial Drug, TR-701
9. Seal Shield Launches Worlds First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control
10. Replidynes Investigational Antibacterial Agent REP3123 Prevents Toxin Production in Clostridium difficile
11. Replidynes Investigational Antibacterial Agent REP3123 Prevents Sporulation in Clostridium difficile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... PINE BROOK, N.J. , Sept. 22, 2014 ... developing antibody therapies to treat infectious disease, today ... adult volunteer safety studies of obiltoxaximab (ETI-204). Obiltoxaximab ... of inhalational anthrax and data from these studies ... when administered intravenously (IV) at the intended therapeutic ...
(Date:9/22/2014)...  AVT, Inc. (OTC Markets: AVTC) ( www.autoretail.com ), ... machines, announced today that they are starting production of ... unit is designed for placement inside optical shops and ... statistics, there are over 20,000 optical stores in ... world,s first automated kiosk dedicated to cleaning and sanitizing ...
(Date:9/22/2014)... , Sept. 22, 2014  Olympus, a ... solutions for medical and surgical procedures, among other ... deal with Munich -based Brainlab ... ® Navigation. This agreement applies to the ... cross-disciplinary U.S. sales and all distribution outside the ...
Breaking Medicine Technology:Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 2Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 3Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 4Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 5Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 6Opticwash Pro Enables Optical Retailers to Generate New Revenues and Customer Traffic through a Unique Eyeglass Cleaning System 2Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 2Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 3Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 4
... Pevion Biotech AG today announced ... therapeutic Candida vaccine PEV7, demonstrating the generation of specific ... Furthermore, the results again confirm the capability of Pevion,s ... long-lasting immunity in humans against otherwise weak antigens ...
... Mass. and MIAMI, Jan. 16, 2012 Boston Scientific ... endpoint data from its ORION trial, demonstrating excellent outcomes ... patients with iliac artery disease, a form of peripheral ... insufficient blood flow.  Results were presented today by Daniel ...
Cached Medicine Technology:Pevion's Therapeutic Candida Vaccine Generates Functional B Cell Memory in all Vaccinees 2Pevion's Therapeutic Candida Vaccine Generates Functional B Cell Memory in all Vaccinees 3Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial 2Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial 3Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial 4Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial 5
(Date:9/22/2014)... Utah (PRWEB) September 23, 2014 ... and corporate training, will be attending and exhibiting ... the American Health Information Management Association (AHIMA) in ... September 27 through October 1, and Career Step ... on its suite of coding training products, including ...
(Date:9/22/2014)... (PRWEB) September 23, 2014 The Marietta ... helping to promote National Breast Cancer Awareness Month ... contribute awareness to cause, prevention, diagnosis, treatment and cure by ... offices across the U.S. , A pink edition Philips ... that can tell us why the Sonicare is important to ...
(Date:9/22/2014)... During the annual Oregon Health Care Association ... care and senior housing industry are recognized for their ... of others. , This year, Nicolette Merino, Regional ... awarded the OHCA Special Service Award. This award is ... assist OHCA in reaching strategic objectives or help achieve ...
(Date:9/22/2014)... York, NY (PRWEB) September 22, 2014 On ... Radio Network launched their first evening show, “KC After Dark.” ... Marcus Edwards, “KC After Dark” will air every Tuesday at ... a free iPad for the 50th caller, and because of ... well past the call in mark with 500 callers. ...
(Date:9/22/2014)... Sterling Heights, MI (PRWEB) September 22, 2014 ... will be partnering with Playworks, a local nonprofit that is ... At least 50 volunteers including UHY employees, their families and ... Americas School to help paint on cement games and graphics, ... , This outing was originally scheduled to occur in ...
Breaking Medicine News(10 mins):Health News:Career Step to Exhibit at AHIMA Convention September 27 through October 1 2Health News:Verde Pointe Dental Associates Participate in Breast Cancer Awareness Month 2014 with a Pink Philips Sonicare Giveaway 2Health News:Avamere Family of Companies Regional Director Nominated for the Oregon Health Care Association 2014 Special Service Award 2Health News:The Women’s Radio Network, WRNW1’s First Evening Show a Huge Success 2Health News:Local CPA Firm Gears Up To Revamp Detroit Elementary School Playground 2Health News:Local CPA Firm Gears Up To Revamp Detroit Elementary School Playground 3
... may soon impact the quality of patient care for ... report. ,Without intervention, the number of allergy-immunology ... demand will increase by 35 percent over the next ... ,The decline in the number of qualified allergists-immunologists ...
... today warned consumers could be seriously misled by proposed new ... to Food Standards Australia and New Zealand (FSANZ), Dr Yong ... confuse consumers and may even contribute to unhealthy diets. ... on labels to encourage consumers to buy their products, Dr ...
... insensitive caption for the picture of an abandoned baby in Melbourne ... left in a cardboard box kept by a Japanese hospital for ... Jikei Hospital in the southern city of Kumamoto to discourage abortions ... ,A small hatch on the side of the hospital has ...
... This high degree of trust and confidence in doctors reflects ... survey reflects the immense efforts from doctors to improve ... the financial pressures placed upon the health service. ... this survey, the majority of respondents have answered that doctors ...
... University of Illinois food science and human nutrition professor ... a persons diet , and safe alternatives to hormone-replacement ... spent a decade evaluating the health effects of isoflavones, ... in soy. Much of his work has focused on ...
... of Wisconsin-Madison have designed a powerful analytical tool capable of ... moving proteins in mid-fold and see the shapes of intermediate ... is that the first applications of the technique offer a ... is implicated in type II diabetes. ,Pancreatic ...
Cached Medicine News:Health News:America on Brink of Allergy Crisis 2Health News:Three-year-old Abandoned in Box Meant for Unwanted Babies in Japan 2Health News:Soy Products a Double-edged Sword for Breast Cancer 2Health News:Soy Products a Double-edged Sword for Breast Cancer 3Health News:New Analytical Tool to Unravel the Cause of Diabetes 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: